Literature DB >> 16765567

Lateralizing value of postictal automatisms in temporal lobe epilepsy.

G Rásonyi1, A Fogarasi, A Kelemen, J Janszky, P Halász.   

Abstract

PURPOSE: To describe clinical characteristics and lateralizing value of postictal automatisms in patients with temporal lobe epilepsy (TLE).
METHODS: One hundred and ninety-three videotaped seizures of 55 consecutive patients with refractory TLE and postoperatively seizure-free outcome were analyzed. Ictal as well as postictal (manual, oral and speech) automatisms were monitored.
RESULTS: Thirty-four (62%) of the 55 patients showed PA at least once during their seizures. Postictal automatism was observed in 70 (36%) attacks as manual (21%), oral (13%) or speech (9%) automatisms. Fifteen seizures contained a combination of two different postictal automatisms. The presence of postictal oral automatisms did not lateralize the seizure onset zone (p=0.834). Speech automatisms (repetitive verbal behavior) occurred more frequently after left-sided seizures (p=0.002). Postictal unilateral manual automatism showed no lateralizing value occurring by the ipsilateral hand in 10 and the contralateral upper limb in 6 seizures (p=0.454).
CONCLUSION: : Postictal automatism is a relatively frequent phenomenon in TLE. Postictal speech automatism lateralizes the seizure onset zone to the left hemisphere. Our observation can help the presurgical evaluation of TLE because verbal perseveration frequently occurs spontaneously, even in seizures without appropriate postictal language testing.

Entities:  

Mesh:

Year:  2006        PMID: 16765567     DOI: 10.1016/j.eplepsyres.2006.05.006

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  1 in total

1.  Postictal clinical and electroencephalographic activity following intracranially recorded bilateral tonic-clonic seizures.

Authors:  Lisa M Bateman; Anil Mendiratta; Jyun-You Liou; Elliot J Smith; Carl W Bazil; Hyunmi Choi; Guy M McKhann; Alison Pack; Shraddha Srinivasan; Catherine A Schevon
Journal:  Epilepsia       Date:  2018-12-21       Impact factor: 5.864

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.